MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, ...
Key Trends, Vendor Performance, and Opportunities Transforming Mexico's Healthcare IT Landscape MIAMI, FLORIDA / ACCESSWIRE / December 24, 2024 / Mexico has emerged as a leader in the transformation ...
Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry Experts to Drive Innovation VICTORIA, BC / ACCESSWIRE / December 24, 2024 / ...
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, ...
The issuer is solely responsible for the content of this announcement. Zurich, 23rd of December 2024: Xlife Sciences AG (SIX: XLS) is pleased to announce that its portfolio company, FUSE-AI GmbH, is ...
LOS ANGELES, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Open Healthcare Inc., a global leader in healthcare services, announces key expansions in the U.S. market through its U.S. division, Open ...
New law limits methods health insurers and PBMs can use to delay and discourage access to medically necessary treatments. ALBANY, NY / ACCESSWIRE / December 23, 2024 / New York Gov. Kathy Hochul ...
China's healthcare digitalization is being driven by urban innovation, government-backed initiatives, and the dominance of local and regional EHR vendors. Black Book explores how these domestic ...
CHICAGO, IL / ACCESSWIRE / December 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative ...
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the "Company", an emerging leader in age-reversal science, today announced significant findings from its copper binding studies with Telomir-1. This is ...
With the addition of these two new assay launches, Zomedica has added 8 new assays in the past 18 months to the rapidly growing TRUFORMA Platform ANN ARBOR, MI / ACCESSWIRE / December 23, 2024 / ...
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback